chloroquine has been researched along with niacinamide in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (41.18) | 18.7374 |
| 1990's | 2 (11.76) | 18.2507 |
| 2000's | 1 (5.88) | 29.6817 |
| 2010's | 7 (41.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Tischendorf, L | 1 |
| Dzizinskiĭ, AA; Katiubin, VP | 2 |
| Hämel, J | 1 |
| Tiess, D | 1 |
| Alberto, R; Lyman, M; May, CD | 1 |
| Adewunmi, AI; Enwonwu, CO; Okolie, EE | 1 |
| Meerson, FZ; Pshennikova, MG; Rysmendiev, AZh; Vorontsova, EIa | 1 |
| BETTLEY, FR | 1 |
| Haystead, TA; Kwiek, JJ; Rudolph, J | 1 |
| Fujita, N; Hayashi, N; Hikita, H; Hiramatsu, N; Hosui, A; Ishida, H; Kanto, T; Kodama, T; Miyagi, T; Shimizu, S; Takehara, T; Tatsumi, T; Tsunematsu, H; Yoshimori, T | 1 |
| Cao, Y; Du, W; Hu, L; Liu, C; Shi, L; Sun, J; Yu, X; Zhang, Y | 1 |
| Dai, Y; Liu, X; Sun, K; Wang, H | 1 |
| Cardiel, MH; Codding, C; Garg, JP; Genovese, MC; Greenwald, M; Kivitz, AJ; Shay, K; Wang, A; Wang, X; Zubrzycka-Sienkiewicz, A | 1 |
| Chesnokova, O; Oleinikov, AV; Oleinikov, IV; Tcherniuk, SO | 1 |
| Ge, M; Jin, S; Li, L; Long, B; Yang, M; Ye, T; Ye, X; Yi, H; Zhang, L | 1 |
2 trial(s) available for chloroquine and niacinamide
| Article | Year |
|---|---|
[Effects of antioxidants and membrane protectors on clinical course and hemodynamics of patients with myocardial infarct].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Chloroquine; Female; Humans; Male; Middle Aged; Myocardial Infarction; Niacinamide; Vitamin E | 1992 |
Peficitinib, a JAK Inhibitor, in Combination With Limited Conventional Synthetic Disease-Modifying Antirheumatic Drugs in the Treatment of Moderate-to-Severe Rheumatoid Arthritis.
Topics: Adamantane; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Chloroquine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Hydroxychloroquine; Janus Kinase 3; Male; Middle Aged; Niacinamide; Severity of Illness Index; Sulfasalazine; Treatment Outcome | 2017 |
15 other study(ies) available for chloroquine and niacinamide
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
[Local nicotinamide therapy in erosive lichen of the oral mucosa].
Topics: Administration, Topical; Chloroquine; Humans; Lichen Planus; Niacinamide; Risk; Stomatitis; Triamcinolone | 1978 |
[Clinical course and necrotic area size in patients with myocardial infarct receiving combined treatment including antioxidants and membrane-protecting agents].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chloroquine; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Myocardial Infarction; Niacinamide; Time Factors; Vitamin E | 1991 |
[Current therapy of chronic lupus erythematosus].
Topics: Chloroquine; Humans; Lupus Erythematosus, Discoid; Niacinamide | 1965 |
[Rapid UV-spectrophotometric determination of toxic materials in samples of stomach contents, with special reference to the relatively less common organic poisons].
Topics: Adult; Aged; Anticonvulsants; Barbiturates; Benzalkonium Compounds; Chemistry, Clinical; Chloroquine; Cholinesterase Inhibitors; Colchicine; Forensic Medicine; Humans; Isoniazid; Methaqualone; Middle Aged; Niacinamide; Nicotine; Oils; Poisons; Promazine; Pyridines; Spectrophotometry; Stomach; Ultraviolet Rays | 1969 |
Effects of compounds which inhibit lymphocyte stimulation on the utilization of glucose by leukocytes.
Topics: Adenine Nucleotides; Adenosine Triphosphate; Carbon Isotopes; Chloroquine; Colchicine; Culture Media; Culture Techniques; Ethanol; Glucose; Humans; Hydrocortisone; Lectins; Leukocytes; Lymphocyte Activation; Lymphocytes; Niacinamide; Ouabain; Theophylline; Time Factors; Tritium | 1970 |
Antimalarial activity of inhibitors of ADP-ribosyl transferase against Plasmodium yoelii infection in mice. 1. Preliminary data.
Topics: Animals; Antimalarials; Benzamides; Chloroquine; Drug Evaluation, Preclinical; Malaria; Male; Mice; Niacinamide; Nucleotidyltransferases; Plasmodium; Poly(ADP-ribose) Polymerases; Theobromine; Theophylline | 1982 |
[Prevention of stress disorders of myocardial contractile function using membrane protectors].
Topics: Animals; Calcium; Chloroquine; Fatty Acids; Humans; Lipase; Myocardial Contraction; Myocardium; Niacinamide; Oxygen; Phospholipases; Propranolol; Rats; Rats, Inbred Strains; Stress Disorders, Post-Traumatic | 1983 |
CHILBLAIN LUPUS ERYTHEMATOSUS.
Topics: Chilblains; Chloroquine; Fluocinolone Acetonide; Frostbite; Humans; Hydroxychloroquine; Hypothyroidism; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Discoid; Lupus Erythematosus, Systemic; Niacinamide; Quinacrine; Telangiectasis; Triamcinolone | 1964 |
Kinetic mechanism of quinone oxidoreductase 2 and its inhibition by the antimalarial quinolines.
Topics: Antimalarials; Binding, Competitive; Chloroquine; Copper; Humans; Kinetics; Niacinamide; Oxidation-Reduction; Primaquine; Quinacrine; Quinolines; Quinone Reductases; Recombinant Proteins; Spectrophotometry; Substrate Specificity; Zinc | 2004 |
Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma.
Topics: Adaptor Proteins, Signal Transducing; Animals; Antineoplastic Agents; Apoptosis; Autophagy; Autophagy-Related Protein 7; Benzenesulfonates; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chloroquine; Drug Resistance, Neoplasm; Humans; Liver Neoplasms; Lysosomes; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Nude; Microtubule-Associated Proteins; Multiprotein Complexes; Niacinamide; Phenylurea Compounds; Proteins; Pyridines; RNA Interference; RNA, Small Interfering; Sequestosome-1 Protein; Sorafenib; TOR Serine-Threonine Kinases; Ubiquitin-Activating Enzymes; Xenograft Model Antitumor Assays | 2012 |
SIRT1 regulates accumulation of oxidized LDL in HUVEC via the autophagy-lysosomal pathway.
Topics: Autophagy; Autophagy-Related Protein 5; Blotting, Western; Cells, Cultured; Chloroquine; Enzyme Inhibitors; Human Umbilical Vein Endothelial Cells; Humans; Lipoproteins, LDL; Lysosomes; Microscopy, Fluorescence; Microtubule-Associated Proteins; Niacinamide; Resveratrol; RNA Interference; Sequestosome-1 Protein; Signal Transduction; Sirtuin 1; Stilbenes; Vitamin B Complex | 2016 |
Inhibition of Autophagy by Chloroquine Enhances the Antitumor Efficacy of Sorafenib in Glioblastoma.
Topics: Animals; Apoptosis; Autophagy; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chloroquine; Glioblastoma; Male; Mice; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Signal Transduction; Sorafenib | 2016 |
Nicotinamide inhibits the growth of P. falciparum and enhances the antimalarial effect of artemisinin, chloroquine and pyrimethamine.
Topics: Animals; Antimalarials; Artemisinins; Cell Line; Cell Survival; Chloroquine; Dose-Response Relationship, Drug; Drug Synergism; Erythrocytes; Humans; Life Cycle Stages; Niacinamide; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrimethamine | 2017 |
Inhibition of autophagy enhances the targeted therapeutic effect of sorafenib in thyroid cancer.
Topics: Animals; Antineoplastic Agents; Autophagy; Autophagy-Related Protein 5; Cell Line, Tumor; Chloroquine; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Signaling System; Mice; Niacinamide; Phenylurea Compounds; Sorafenib; Thyroid Neoplasms; Treatment Outcome; Xenograft Model Antitumor Assays | 2018 |